Company RLS Global AB (publ)

RLS

SE0005190725

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

RLS Global AB, formerly OraSolv Products AB, is a Sweden-based company engaged in the development of dental care products. It is primarily engaged in the development of biochemical products and methods for minimally invasive dentistry. The Company's product portfolio includes Carisolv, a biochemical method for the removal of caries; Perisolv, product for the treatment of periodontitis; ChloraSolv, a treatment that cleanses and heals chronic wounds and Kindersolv, a caries treatment for children. The Company manufactures its products in the Sahlgrenska Science Park and sells them through distributors worldwide. The Company's main shareholders are Rls Global Intressenter AB, Joki Invest AB, Zebra Holdings and Investments Limited.

Number of employees: 9

Managers	Title	Age	Since
Roland Frösing CEO	Chief Executive Officer	64	01/21/01
Torbjörn Sannerstedt DFI	Director of Finance/CFO	64	22/23/22
Magnus Nolmark COO	Chief Operating Officer	59	01/21/01
Susanne Olausson CTO	Chief Tech/Sci/R&D Officer	53	01/17/01

Members of the board	Title	Age	Since
Hans Christer Erik Hägglund BRD	Director/Board Member	71	01/12/01
Karin Birgitta Eliasson BRD	Director/Board Member	63	01/17/01
Anders Edvell BRD	Director/Board Member	55	01/23/01
Roland Frösing CEO	Chief Executive Officer	64	01/21/01
Lars Johansson CHM	Chairman	58	01/23/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	79,874,705	41,780,367 ( 52.31 %)	0	52.31 %

RLS Global AB

Neongatan 5

431 53, Moelndal

+46 3 17 80 68 20

http://www.rlsglobal.se

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+33.25%	704B
NOVO NORDISK A/S	+28.59%	577B
JOHNSON & JOHNSON	-3.55%	348B
MERCK & CO., INC.	+18.16%	327B
ABBVIE INC.	+4.36%	288B
ASTRAZENECA PLC	+14.81%	234B
NOVARTIS AG	+4.93%	198B
ROCHE HOLDING AG	-9.78%	194B
AMGEN INC.	-3.69%	147B

Other Pharmaceuticals